Coste Catherine 4
4 · Renalytix plc · Filed Jul 7, 2023
Insider Transaction Report
Form 4
Renalytix plcRNLX
Coste Catherine
Director
Transactions
- Award
Employee Stock Option (right to buy)
2023-07-06+190,000→ 190,000 totalExp: 2033-07-05→ Ordinary Shares (190,000 underlying)
Footnotes (2)
- [F1]The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269).
- [F2]One third (1/3rd) of the shares subject to the option award shall vest on July 6, 2024, and one eighth (1/8th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service.